Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes
Completed
Conditions studied: Cardiac Arrhythmia
In brief
To determine the associations among biometric data and previously reported medication changes in the original MAPS study
Key facts
- Study ID
- NCT05505136
- Run by
- Zoll Medical Corporation
- People needed
- 62
- Starts
- 2022-08-30
- Expected to finish
- 2023-05-15
- Last updated by the study team
- 2023-06-18
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- those that completed the MAPS study and that had medication changes based wholly or in part on biometric information.
You may not qualify if…
- Those patients from the MAPS study that did not have medication changes.
Where it is running
- Cardiovascular Institute of Central Florida — Ocala, Florida, United States
- First Coast Heart & Vascular Center — Saint Augustine, Florida, United States
- Jackson Heart Clinic — Jackson, Mississippi, United States
- PharmaTex Research — Amarillo, Texas, United States
- Texas Cardiology Associates of Houston — Kingwood, Texas, United States
- CardioVoyage — McKinney, Texas, United States
- Dr. Daniel W. Gottlieb — Burien, Washington, United States
- St. Mary's Medical Center EP — Huntington, West Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.